1203008

Dihydrostreptomycinsulfat

United States Pharmacopeia (USP) Reference Standard

• Synonym(e): Dihydrostreptomycin -sesquisulfat
• Lineare Formel: C₂₁H₄₁N₇O₁₂ · 3/2H₂SO₄
• CAS-Nummer: 5490-27-7
• Molekulargewicht: 730.71
• UNSPSC Code: 41116107
• NACRES: NA.24
• PubChem Substance ID: 329749599
• MDL number: MFCD00070252
• Beilstein/REAXYS Number: 3894221

Eigenschaften

• grade: pharmaceutical primary standard
• agency: USP
• API family: dihydrostreptomycin
• form: solid
• mol wt: monograph mol wt. 1461.44
• manufacturer/tradename: USP
• application(s): USP Biologics; pharmaceutical (small molecule)
• format: neat
• SMILES string: OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@@H](O[C@@H](C)[C@]2(O)CO)O[C@@H]3[C@@H](O)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]3NC(N)=N.CN[C@H]4[C@H](O)[C@@H](O)[C@H](CO)O[C@H]4O[C@H]5[C@@H](O[C@@H](C)[C@]5(O)CO)O[C@@H]6[C@@H](O)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]6NC(N)=N
• InChI: 1S/2C21H41N7O12.3H2O4S/c2*1-5-21(36,4-30)16(40-17-9(26-2)13(34)10(31)6(3-29)38-17)18(37-5)39-15-8(28-20(24)25)11(32)7(27-19(22)23)12(33)14(15)35;3*1-5(2,3)4/h2*5-18,26,29-36H,3-4H2,1-2H3,(H4,22,23,27)(H4,24,25,28);3*(H2,1,2,3,4)/t2*5-,6-,7-,8+,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,21+;;;/m00.../s1
• InChI key: CZWJCQXZZJHHRH-YZTFXSNBSA-N

Beschreibung

General description

Find answers to frequently asked questions on USP products in USP FAQs.

Dihydrostreptomycin sulfate is a semi-synthetic aminoglycoside antibiotic derived from streptomycin. It binds to bacterial ribosomes, disrupting protein synthesis. The USP standard supports microbiological testing and chromatographic identity confirmation.

The USP biologics antibiotics category includes a wide range of antimicrobial agents that are essential in treating bacterial infections. These antibiotics are derived from various natural sources or synthesized to combat specific pathogens effectively. The USP provides comprehensive standards, reference materials, and analytical procedures to ensure the identity, quality, purity, and consistency of antibiotic therapeutics throughout their lifecycle.

The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics.

Application

Dihydrostreptomycin sulfate USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Dihydrostreptomycin Injection
• Dihydrostreptomycin Sulfate
• Dihydrostreptomycin Sulfate Boluses
• Penicillin G Procaine and Dihydrostreptomycin Sulfate Injectable Suspension
• Penicillin G Procaine and Dihydrostreptomycin Sulfate Intramammary Infusion
• Penicillin G Procaine, Dihydrostreptomycin Sulfate, Chlorpheniramine Maleate, and Dexamethasone Injectable Suspension

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

((C₂₁H₄₁N₇O₁₂)₂ · 3H₂SO₄)

Sales restrictions may apply.

This product is part of the USP Biologics program.

Sicherheitshinweise

• pictograms: GHS08,GHS07
• signalword: Warning
• hcodes: H302,H361fd
• pcodes: P280 - P301 + P312 + P330
• Hazard Classifications: Acute Tox. 4 Oral - Repr. 2
• Lagerklasse: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable